{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:32:28Z","timestamp":1793248348680,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.bone.2026.118137","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:39:48Z","timestamp":1792391988000},"page":"118137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical phenotype and bone microarchitecture of cutaneous-skeletal hypophosphatemia syndrome: experience from a single center in China"],"prefix":"10.1016","volume":"215","author":[{"given":"Shuquan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Jiajue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7337-9982","authenticated-orcid":false,"given":"Yue","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bone.2026.118137_bb0005","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1007\/s00198-016-3702-8","article-title":"Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment","volume":"27","author":"Ovejero","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2026.118137_bb0010","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2015.11.012","article-title":"Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy","volume":"75","author":"Lim","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.bone.2026.118137_bb0015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ajmg.c.32021","article-title":"Mosaic RASopathies: A review of disorders caused by somatic pathogenic variants in the genes of the RAS\/MAPK pathway","volume":"190","author":"Carli","year":"2022","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"2","key":"10.1016\/j.bone.2026.118137_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddt429","article-title":"Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia","volume":"23","author":"Lim","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.bone.2026.118137_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159330","article-title":"Murine models of HRAS-mediated cutaneous skeletal hypophosphatemia syndrome suggest bone as the FGF23 excess source","volume":"133","author":"Ovejero","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2026.118137_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116598","article-title":"The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome","volume":"166","author":"Sugarman","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.118137_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.866831","article-title":"A Case Report: First Long-Term Treatment With Burosumab in a Patient With Cutaneous-Skeletal Hypophosphatemia Syndrome","volume":"13","author":"Merz","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bone.2026.118137_bb0040","article-title":"Burosumab treatment in a child with cutaneous skeletal hypophosphatemia syndrome: A case report","volume":"15","author":"Khadora","year":"2021","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2026.118137_bb0045","article-title":"A case report to assess the safety and efficacy of Burosumab, an investigational antibody to FGF23, in a single pediatric patient with Epidermal Nevus Syndrome and associated hypophosphatemic rickets","volume":"17","author":"Huynh","year":"2022","journal-title":"Bone Rep."},{"issue":"6","key":"10.1016\/j.bone.2026.118137_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.64020","article-title":"Burosumab treatment in a girl with cutaneous skeletal hypophosphatemia syndrome: 2-year follow-up","volume":"197","author":"Del Pino","year":"2025","journal-title":"Am. J. Med. Genet. A"},{"issue":"10","key":"10.1016\/j.bone.2026.118137_bb0055","article-title":"Burosumab, a transformational treatment in a pediatric patient with cutaneous-skeletal hypophosphatemia syndrome","volume":"2","author":"da Silva","year":"2024","journal-title":"JCEM Case Rep."},{"issue":"12","key":"10.1016\/j.bone.2026.118137_bb0060","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/gcc.23092","article-title":"Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndrome","volume":"61","author":"Carli","year":"2022","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bone.2026.118137_bb0065","article-title":"Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome","volume":"20","author":"Abebe","year":"2024","journal-title":"Bone Rep."},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13023-025-03801-5","article-title":"Targeted treatment of hypophosphatemia with trametinib in HRAS-related mosaic RASopathy","volume":"20","author":"Mirza","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00223-025-01373-x","article-title":"A Child with Cutaneous-Skeletal Hypophosphatemia Syndrome Caused by a Mosaic HRAS Mutation: Outcome of Treatment with Anti-FGF23 Antibody","volume":"116","author":"Wu","year":"2025","journal-title":"Calcif. Tissue Int."},{"issue":"12","key":"10.1016\/j.bone.2026.118137_bb0080","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1210\/jc.2005-1258","article-title":"In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography","volume":"90","author":"Boutroy","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2026.118137_bb0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11914-013-0140-9","article-title":"High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group","volume":"11","author":"Cheung","year":"2013","journal-title":"Curr. Osteoporos. Rep."},{"issue":"5","key":"10.1016\/j.bone.2026.118137_bb0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nrrheum.2014.23","article-title":"High-resolution in vivo imaging of bone and joints: a window to microarchitecture","volume":"10","author":"Geusens","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.bone.2026.118137_bb0095","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/clinem\/dgae782","article-title":"Bone Microarchitecture Evaluated by HR-PQCT in Chinese Adolescent and Pediatric Patients With X-Linked Hypophosphatemia","volume":"110","author":"Wu","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118137_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116423","article-title":"Bone microstructure evaluated by TBS and HR-pQCT in Chinese adults with X-linked hypophosphatemia","volume":"160","author":"Ni","year":"2022","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bone.2026.118137_bb0105","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00198-016-3543-5","article-title":"Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type","volume":"27","author":"El-Maouche","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.118137_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.883981","article-title":"Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets\/Osteomalacia Versus X-linked Hypophosphatemia in Chinese Adolescents","volume":"13","author":"Jiajue","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.bone.2026.118137_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"19","key":"10.1016\/j.bone.2026.118137_bb0120","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2026.118137_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jbmr.4476","article-title":"Bone impairment in a large cohort of Chinese patients with tumor-induced osteomalacia assessed by HR-pQCT and TBS","volume":"37","author":"Ni","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0130","first-page":"43","article-title":"Pediatric Reference Intervals for Biochemical Markers: Gaps and Challenges, Recent National Initiatives and Future Perspectives","volume":"28","author":"Tahmasebi","year":"2017","journal-title":"Ejifcc"},{"issue":"5","key":"10.1016\/j.bone.2026.118137_bb0135","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","article-title":"Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children","volume":"58","author":"Colantonio","year":"2012","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0140","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1210\/jc.2013-2813","article-title":"Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23","volume":"99","author":"Avitan-Hersh","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2026.118137_bb0145","first-page":"665","article-title":"Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic HRAS Mutation","volume":"48","author":"Park","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.bone.2026.118137_bb0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/pde.14139","article-title":"Hypophosphatemic rickets: A rare complication of congenital melanocytic nevus syndrome","volume":"37","author":"Welfringer-Morin","year":"2020","journal-title":"Pediatr. Dermatol."},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ced.12969","article-title":"Mosaic NRAS Q61R mutation in a child with giant congenital melanocytic naevus, epidermal naevus syndrome and hypophosphataemic rickets","volume":"42","author":"Ramesh","year":"2017","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.bone.2026.118137_bb0160","article-title":"Surgical management strategies and clinical outcomes of cutaneous skeletal hypophosphatemia syndrome: a case series","volume":"13","author":"Qiao","year":"2025","journal-title":"Front. Pediatr."},{"issue":"8","key":"10.1016\/j.bone.2026.118137_bb0165","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2013.24","article-title":"Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell","volume":"133","author":"Groesser","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bone.2026.118137_bb0170","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/EJE-19-0969","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia\/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome","volume":"182","author":"de Castro","year":"2020","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2026.118137_bb0175","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2017.05.059","article-title":"Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis","volume":"78","author":"Krooks","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.bone.2026.118137_bb0180","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","article-title":"Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism","volume":"18","author":"Kawata","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2026.118137_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.bone.2026.118137_bb0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11154-015-9318-z","article-title":"The PTH-Vitamin D-FGF23 axis","volume":"16","author":"Blau","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"19","key":"10.1016\/j.bone.2026.118137_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14192229","article-title":"Superscan pattern on bone scintigraphy: a comprehensive review","volume":"14","author":"Askari","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.bone.2026.118137_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.bone.2026.118137_bb0205","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00003072-198606000-00015","article-title":"Scintigraphic manifestation of fibrous dysplasia","volume":"11","author":"Machida","year":"1986","journal-title":"Clin. Nucl. Med."},{"issue":"7","key":"10.1016\/j.bone.2026.118137_bb0210","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jbmr.2310","article-title":"Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets","volume":"30","author":"Shanbhogue","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2026.118137_bb0220","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1210\/jc.2012-4133","article-title":"Cortical and trabecular bone density in X-linked hypophosphatemic rickets","volume":"98","author":"Cheung","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118137_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117179","article-title":"Evaluation of bone density and microarchitecture in adult patients with X-linked hypophosphatemic rickets: A pilot longitudinal study","volume":"187","author":"Funck-Brentano","year":"2024","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2026.118137_bb0230","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00198-017-3949-8","article-title":"Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets","volume":"28","author":"Colares Neto","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"5","key":"10.1016\/j.bone.2026.118137_bb0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00774-023-01442-x","article-title":"Evaluation of the trabecular bone score in 35 children and adults with X-linked hypophosphatemic rickets","volume":"41","author":"de Paula Colares Neto","year":"2023","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(91)90507-T","article-title":"X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry","volume":"90","author":"Reid","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2026.118137_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115106","article-title":"Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization","volume":"130","author":"Fowlkes","year":"2020","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2026.118137_bb0250","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-018-03720-z","article-title":"Somatic activating mutations in MAP2K1 cause melorheostosis","volume":"9","author":"Kang","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:59:32Z","timestamp":1793246372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226003637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":50,"alternative-id":["S8756328226003637"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118137","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical phenotype and bone microarchitecture of cutaneous-skeletal hypophosphatemia syndrome: experience from a single center in China","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118137"}}